Can-Fite BioPharma Investor Relations Material
Latest events
C-level Sitdown
Can-Fite BioPharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Can-Fite BioPharma Ltd
Access all reports
Can-Fite BioPharma Ltd is an Israel-based clinical-stage biopharmaceutical company focused on developing oral small molecule drugs for the treatment of cancer, liver, and inflammatory diseases. The company’s drug candidates target the A3 adenosine receptor, which is highly expressed in pathological cells. Its pipeline includes treatments for conditions such as liver cancer, psoriasis, and osteoarthritis. Can-Fite conducts clinical trials and collaborates with international research institutions. The company is headquartered in Petah Tikva, Israel, and its shares are listed on the NYSE American.
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
CANF
Country
🇮🇱 Israel